Abstract:Lamellarin D, a marine natural product, acts as a potent inhibitor of DNA topoisomerase I (Topo I). To modify its physicochemical property and biological activity, a series of mono- and di- glycosylated derivatives were designed and synthesized through 22-26 multi-steps. Their inhibition of human Topo I was evaluated, and most of the glycosylated derivatives exhibited high potency in inhibiting Topo I activity as well as lamellarin D. All the 15 target compounds were evaluated for their cytotoxic activities against five human cancer cell lines. The typical lamellarin derivative ZL-3 exhibited the best activity with IC50 values of 3 nM, 10 nM, and 15 nM against human lung cancer A549 cells, human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells. Compound ZL-1 exhibited anti-cancer activity with IC50 of 14 nM and 24 nM against human colon cancer HCT116 cells and human hepatocellular carcinoma HepG2 cells, respectively. Cell cycle analysis in MDA-MB-231 suggested ZL-3 inhibited cell growth through arresting cells at the G2/M phase of the cell cycle. Further tests showed a significant improvement in aqueous solubility of ZL-1 and ZL-7. This study suggested that glycosylation could be utilized as a useful strategy to optimize lamellarin D derivatives as Topo I inhibitors and anticancer agents. (C) 2021 Elsevier Masson SAS. All rights reserved.

Total Synthesis of Lycogarubin C and Lycogalic Acid A

Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D

Total Synthesis of (-)-5,6-dihydrocineromycin B

Indium-Mediated Allylation Reaction in Aqueous Media: Synthetic Studies Towards the Total Synthesis of Dysiherbaine

Total Synthesis of (-)-retigeranic Acid A: A Reductive Skeletal Rearrangement Strategy.

Collective Synthesis of Lycopodium Alkaloids and Tautomer Locking Strategy for the Total Synthesis of (-)-lycojapodine A

Total Syntheses of Lycoposerramine-V and 5-Epi-lycoposerramine-v.

Divergent Total Syntheses of (-)-lycopladine D, (+)-Fawcettidine, and (+)-Lycoposerramine Q

Total Syntheses of Nigrasin I and Kuwanon C

Total Synthesis of Polysubstituted γ-Butyrolactone Lignans (-)-Hinokinin, (-)-Bicubebin B, and (-)-Isodeoxypodophyllotoxin via Oxime Carbonate Formation

Total Synthesis of Suberitines A-D Featuring Tunable Biomimetic Late-Stage Oxidative Dearomatization and Acetalization.

Total Synthesis Of (-)-Goniomitine

Catalytic, Asymmetric Total Synthesis of (+)-α-, (+)-β-, (+)-γ-, and (−)-δ-Lycorane

Biomimetic Syntheses of Rubialatins A, B and Related Congeners

Total Synthesis of Huperserratines A and B

A Facile Total Synthesis of (3R,7RS)-3,7,11-Trimethyl-10-oxododecanoic Acid

Total Synthesis of Maremycins A, B, C-1/C-2, D-1, and D-2

A Concise Approach for the Total Synthesis of Pseudolaric Acid A.

Asymmetric Total Syntheses of (-)-α-Lycorane, (-)-Zephyranthine, and Formal Synthesis of (+)-Clivonine.

Divergent Total Syntheses of (−)-Huperzine Q, (+)-Lycopladine B, (+)-Lycopladine C, and (−)-4-epi-Lycopladine D

Total Synthesis of Lamellarins D, H, and R and Ningalin B